Lunai Bioworks (Nasdaq: LNAI) Signs Definitive Collaboration Agreement with BrainStorm Therapeutics; Initial Parkinson's Disease Data Readout Targeted for First Half of 2027 | LNAI Stock NewsStockTitan·2 days ago, 06:28 AMBCLI-76.00%LNAI-202.00%
BrainStorm names ex-FDA official Peter Pitts executive chairman, Frenkel becomes senior adviserPUBT·Jul 30 at 04:08 PMBCLI-76.00%
Lunai Bioworks and BrainStorm Therapeutics Launch Foundation-Funded Parkinson's and Rare Epilepsy AI Discovery Collaboration | LNAI Stock NewsStockTitan·May 28 at 12:15 AMBCLI-76.00%LNAI-202.00%
BrainStorm Cell Therapeutics Appoints Former FDA Associate Commissioner Peter J. Pitts to Board of Directors | BCLI Stock NewsStockTitan·May 27 at 10:45 PMBCLI-76.00%
BrainStorm Cell Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update | BCLI Stock NewsStockTitan·May 15 at 07:05 AMBCLI-76.00%
